The In Vitro Diagnostics Quality Control Market is gaining importance as clinical laboratories and healthcare providers place greater emphasis on accurate, reliable, and consistent diagnostic testing. The market was valued at USD 1.3 billion in 2023 and is projected to grow from USD 1.4 billion in 2026 to USD 1.6 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030. The increasing number of certified clinical laboratories and growing patient confidence in dependable IVD-based diagnostic services are supporting market demand.

Download a free sample copy of the In Vitro Diagnostics Quality Control market report to understand detailed coverage and inclusions in the final report

Market Growth and Demand Landscape

The growing need for clinical diagnostic testing is creating sustained demand for IVD quality control products. Rising prevalence of chronic and infectious diseases has increased the importance of accurate laboratory testing, while laboratories are increasingly pursuing accreditation to meet industry standards, expand testing volumes, and strengthen patient confidence.

The market is also influenced by regulatory requirements and the need for continuous quality checks. Quality control helps laboratories verify the performance of diagnostic tests and maintain reliable results. Third-party quality control services are gaining popularity because they provide independent assessments across different test systems and help laboratories maintain safety and analytical accuracy.

Product and Type Insights

Controls represented the leading product segment, accounting for 48.3% of the market in 2023. These products are essential for maintaining the accuracy, reliability, and consistency of diagnostic testing. Increasing chronic disease prevalence and the need for precise diagnostic examinations are supporting demand for controls.

Calibrators are anticipated to register the fastest CAGR during the forecast period. These reference materials contain known concentrations of analytes and help laboratories standardize diagnostic assays and establish reliable relationships between instrument signals and analyte concentrations.

By type, quality controls held the largest market revenue share in 2023 and are anticipated to register the fastest CAGR over the forecast period. Data management solutions are also expected to grow significantly as laboratories seek better connectivity between diagnostic instruments, Laboratory Information Systems, and data management platforms.

Application and Manufacturer Landscape

Immunochemistry held the largest market revenue share by application in 2023. Its high sensitivity and specificity support precise measurement of analytes present at low concentrations. Automated and high-throughput immunoassay platforms are also improving workflow efficiency and analytical performance.

Clinical chemistry is anticipated to register the fastest CAGR during the forecast period. It covers analysis of biochemical components such as glucose, electrolytes, enzymes, proteins, lipids, hormones, and drugs. Continued development of clinical chemistry analyzers is supporting segment opportunities.

Third-party controls held the largest market revenue share by manufacturer type in 2023, while OEM controls are anticipated to register the fastest CAGR. OEM solutions are designed around specific diagnostic instruments and are increasingly associated with customization, flexibility, automation, and system integration.

End-use and Regional Market Outlook

The home care segment held the largest market revenue share in 2023, supported by point-of-care testing that enables diagnostic procedures outside traditional laboratory environments. The hospital segment is anticipated to register the fastest CAGR as hospitals strengthen quality assurance, standardized testing procedures, proficiency testing, and continuous equipment monitoring.

North America dominated the market with a 47.1% revenue share in 2023. Established healthcare infrastructure, healthcare expenditure, advanced diagnostic systems, and demand for internal and external quality control solutions contribute to its position.

Asia Pacific is expected to be the fastest-growing market during the forecast period. Increasing IVD manufacturing activity, greater awareness of early and precise diagnosis, healthcare development, and regulatory initiatives are supporting expansion. Europe is also expected to grow significantly, driven by established clinical diagnostic industries, research initiatives, and adoption of quality control products.

Competitive Landscape and Technology Trends

Recent developments include Merck KGaA launching ChemisTwin in November 2023, Randox Laboratories Ltd acquiring Cellix Limited in June 2023, ZeptoMetrix launching PROtrol in May 2023, SeraCare releasing Seraseq BRCA1/2 large genomic rearrangements reference materials in March 2023, and QIAGEN launching the EZ2 Connect MDx IVD platform in January 2023. These developments highlight the industry's focus on automation, reference materials, diagnostic accuracy, and laboratory efficiency.

FAQ

How big is the In Vitro Diagnostics Quality Control Market?

The market was valued at USD 1.3 billion in 2023, is estimated at USD 1.4 billion in 2026, and is projected to reach USD 1.6 billion by 2030, growing at a CAGR of 3.2% from 2024 to 2030.

What trends are shaping the In Vitro Diagnostics Quality Control Market?

Increasing diagnostic testing, laboratory accreditation, third-party quality control services, automation, data management, regulatory scrutiny, and development of advanced quality control and calibration solutions are shaping the market.

Key In Vitro Diagnostics Quality Control Companies:

·        Siemens Healthineers AG

·        Abbott

·        Bio-Rad Laboratories

·        Danaher

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.